Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

Bausch + Lomb

Status and phase: Completed; Phase 2

Conditions: Dry Eye Disease

Treatments: Drug: bromfenac ophthalmic solution 0.06%

Study type: Interventional

Funder types: Industry

Identifiers

NCT00758784

CL-S&E-0417082-P

Details and patient eligibility

About

The purpose of this study is to investigate the safety and efficacy of an ophthalmic solution in dry eye disease.

Enrollment: 38 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects 18 years of age or older

Exclusion criteria

• No active ocular conditions of disease

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

38 participants in 1 patient group

bromfenac ophthalmic solution 0.06%

Experimental group

Description:

bromfenac ophthalmic solution 0.06% bilaterally twice a day

Treatment:

Drug: bromfenac ophthalmic solution 0.06%